Wungki Park
机构：Memorial Sloan Kettering Cancer Center, Cornell University · ORCID：0000-0002-8006-3102
发表论文 281 篇 · 总被引 7455 次 · h-index 34
代表论文
- Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer (2026 · Nature Medicine · 被引 3)
- Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond (2026 · Targeted Oncology · 被引 2)
- Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer (2026 · Clinical Cancer Research · 被引 2)
- Pancreatic Cancer: Translating Tumor Biology into Actionability (2026 · Cancer Discovery · 被引 1)
- Supplementary Figure S4 from Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer (2026)
- Supplementary Figure S2 from Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer (2026)